HarborPath Appoints Susanna Naggie, MD, MHS to its Board of Directors
Columbia, SC – July 14, 2015 HarborPath, a non-profit organization dedicated to assisting low-income, uninsured people living with HIV/AIDS and hepatitis C gain access to their entire regimen of prescription medications at no cost through a streamlined online portal, has appointed Susanna Naggie, MD, MHS to its Board of Directors. Dr. Naggie is currently an Associated Professor of Medicine at Duke University Medical Center (DUMC) where she holds appointments at the Duke Clinical Research Institute (DCRI, Director of ID Research) as well as at the Durham Veterans Affairs Medical Center (DVAMC).
“Dr. Naggie is well-known both for her commitment to patients living with HIV/AIDS and hepatitis C, as well as for her extensive and highly regarded research into hepatitis C ” remarked Ken Trogdon, Jr., President of HarborPath. “We are honored to have her as the newest member of our board of directors. I believe that her expertise will play a vital role relevant to our current efforts serving the uninsured and the healthcare professionals who have come to rely on the safety-net solution of HarborPath.”
Dr. Susanna Naggie completed her medical education at Johns Hopkins School of Medicine and her internal medicine training at Duke University Medical Center (DUMC). She completed her Infectious Diseases (ID) fellowship training at Duke in July 2009 and then joined the faculty in the Division of ID. She currently leads two multidisciplinary HIV and viral hepatitis clinics, providing patient care to mono-infected and co-infected persons and developing research protocols relevant to the clinical care of this population. Dr. Naggie is a member of the AASLD/IDSA HCV Guidance Committee, the AIDS Clinical Trials Group Viral Hepatitis Transformative Science Group Committee, and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline Committee.
“Thank you for the opportunity to join the HarborPath Board, and I am eager to work collaboratively serving patients who are falling through the cracks, in many cases regardless of insurance coverage. Medication access is crucial to saving lives and preventing severe complications caused by HIV and hepatitis C,” said Dr. Naggie.
Mike Beyer Sam Brown Inc. PR for HarborPath
Ken Trogdon, Jr.